Risedronic acidUnmasking of ocular myasthenia gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87159-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：341 / 341

相关论文

共 50 条

[41] NivolumabMyositis and myasthenia gravis: case report
Reactions Weekly, 2018, 1719 (1) : 166 - 166
[42] Schizophrenia and myasthenia gravis: a case report
Kuharic, D. Bosnjak
Sabo, T.
Sakoman, A. Jambrosic
Herceg, M.
EUROPEAN PSYCHIATRY, 2023, 66 : S1050 - S1050
[43] SintilimabMyocarditis and myasthenia gravis: case report
Reactions Weekly, 2021, 1877 (1) : 364 - 364
[44] DurvalumabDermatomyositis and myasthenia gravis: case report
Reactions Weekly, 2021, 1870 (1) : 121 - 121
[45] PembrolizumabMyocarditis and myasthenia gravis: case report
Reactions Weekly, 2020, 1832 (1) : 247 - 247
[46] PembrolizumabExacerbation of myasthenia gravis: case report
Reactions Weekly, 2018, 1701 (1) : 233 - 233
[47] NivolumabMyocarditis and myasthenia gravis: case report
Reactions Weekly, 2021, 1876 (1) : 260 - 260
[48] EstrogenExacerbation of myasthenia gravis: case report
Reactions Weekly, 2010, 1304 (1) : 17 - 17
[49] Marathons and myasthenia gravis: a case report
Birnbaum, Simone
Sharshar, Tarek
Eymard, Bruno
Theaudin, Marie
Portero, Pierre
Hogrel, Jean-Yves
BMC NEUROLOGY, 2018, 18
[50] AdalimumabOcular myasthenia gravis: case report
Reactions Weekly, 2020, 1827 (1) : 14 - 14

← 1 2 3 4 5 →